FIELD: medicine.
SUBSTANCE: invention relates to chemical-pharmacological industry, namely to creation of preparation for controlling glycemia level and prevention of vascular complications in patients with disorders of carbohydrate metabolism and type 2 diabetes mellitus. As said preparation, applied is BAA to food "Carb blocker Phase2/Phasa2®".
EFFECT: preparation has good tolerance and does not have side effects, allows prevention or considerably slow down of development of vascular complications at reaching state of compensation/subcompensation of carbohydrate metabolism.
4 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF TYPE 2 DIABETES MELLITUS | 2005 |
|
RU2304976C1 |
| AGENT FOR PREVENTING AND TREATING INSULIN-INDEPENDENT DIABETES | 2011 |
|
RU2458701C1 |
| METHOD FOR DETERMINATION TYPE 1 DIABETES COMPENSATION FOR ADOLESCENTS | 2015 |
|
RU2613272C1 |
| METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION IN PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE IN METABOLIC SYNDROME | 2019 |
|
RU2715242C1 |
| METHOD DETERMINING TACTICS OF CARRYING OUT OF MEDICAL ACTIONS AT PATIENTS WITH METABOLIC SYNDROME AGAINST ARTERIAL HYPERTENSIA | 2007 |
|
RU2337612C1 |
| METHOD OF TREATING DIABETES MELLITUS IN OUTCOME OF TOTAL DUODENOPANCREATECTOMY | 2023 |
|
RU2823874C1 |
| METHOD FOR CORRECTION OF POST-PRANDIAL GLYCEMIA | 2022 |
|
RU2805492C9 |
| METHOD OF TREATING ABDOMINAL OBESITY IN CASE OF METABOLIC SYNDROME | 2013 |
|
RU2548709C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF TYPE 2 DIABETES MELLITUS WITH APPLICATION OF VARIOUS TYPES OF GLUCOSE-LOWERING THERAPY ON THE BASIS OF ESTIMATION OF GLYCEMIA VARIABILITY | 2019 |
|
RU2723626C1 |
| METHOD FOR TREATING PREDIABETES IN PERSONS WITH EXTERNAL EATING BEHAVIOR | 2022 |
|
RU2805361C1 |
